SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Combat Drugs shines on getting nod to divest Singapore subsidiary

06 Nov 2019 Evaluate

Combat Drugs is currently trading at Rs. 21.90, up by 1.00 points or 4.78% from its previous closing of Rs. 20.90 on the BSE.

The scrip opened at Rs. 21.05 and has touched a high and low of Rs. 21.90 and Rs. 19.95 respectively. So far 4741 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 30.40 on 14-Nov-2018 and a 52 week low of Rs. 16.20 on 19-Sep-2019.

Last one week high and low of the scrip stood at Rs. 21.90 and Rs. 19.80 respectively. The current market cap of the company is Rs. 17.52 crore.

The promoters holding in the company stood at 58.00%, while Institutions and Non-Institutions held 0.00% and 42.00% respectively.

Combat Drugs has received an approval for the full Disinvestment of the Fully Owned Subsidiary of the company in Singapore i.e. RA Labs by sale of entire Equity Shares held by the company, at cost, subject to shareholder approval and other statutory approvals, as applicable, if any. The Board of Directors of the company in their meeting approved the same.

Combat Drugs manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments.


Decipher Labs Share Price

7.51 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×